As of May 2026, FDA has also proposed excluding compounded semaglutide, tirzepatide, and liraglutide from the 503B Bulks List, with a public comment period closing June 29, 2026
What is semaglutide, and which brands contain it
Novo Nordisk Targets Hims & Hers Compounded Semaglutide Offerings in Patent Lawsuit February 18, 2026 Caleb Harris On February 9, 2026, Novo Nordisk A/S and Novo Nordisk Inc
Its important to note that not everyone experiences these side effects, and they can often be managed with the guidance of a healthcare provider
You should never start a GLP-1 medication obtained without a prescription or without disclosing your full medication list to a licensed provider